Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
methylprednisolone acetate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Generic mfg.
Drug class:
GCR agonist
Related drugs:
‹
dexamethasone (18)
dexamethasone tablets (1)
dexamethasone acetate high-dose (0)
dexamethasone injection (0)
methylprednisolone oral (0)
methylprednisolone sodium succinate (0)
prednisolone (0)
dexamethasone (18)
dexamethasone tablets (1)
dexamethasone acetate high-dose (0)
dexamethasone injection (0)
methylprednisolone oral (0)
methylprednisolone sodium succinate (0)
prednisolone (0)
›
Associations
News
Trials
Filter by
Latest
7d
The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint (clinicaltrials.gov)
P4, N=61, Completed, University of Alberta | Active, not recruiting --> Completed | N=90 --> 61 | Trial primary completion date: Dec 2025 --> Sep 2025
7 days ago
Trial completion • Enrollment change • Trial primary completion date
|
methylprednisolone acetate
11d
PRIMERA001: Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point of view. Tailoring of treatment is done by taking the presence of autoantibodies and the quick response to glucocorticoids and JAK inhibitors into account. (2024-511530-12-01)
P4, N=300, Active, not recruiting, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Not yet recruiting --> Active, not recruiting
11 days ago
Enrollment closed
|
hydroxychloroquine • Simponi (golimumab) • leflunomide • methylprednisolone acetate
17d
Hoffa's Fat Pad Impingement (HFPI) (clinicaltrials.gov)
P4, N=62, Recruiting, Boston Children's Hospital | Not yet recruiting --> Recruiting | Phase classification: PN/A --> P4 | Not yet recruiting --> Recruiting
17 days ago
Enrollment open • Phase classification
|
methylprednisolone acetate • octreotide acetate
2ms
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial (clinicaltrials.gov)
P=N/A, N=45, Completed, Arthrex, Inc. | Trial completion date: Jul 2026 --> Feb 2026 | Active, not recruiting --> Completed
2 months ago
Trial completion • Trial completion date
|
methylprednisolone acetate
2ms
The efficacy and safety of Intramuscular Methylprednisolone in patients with Hand OsteoArthritis: the IMHOA trial (2024-518344-20-00)
P2/3, N=212, Recruiting, Sint Maartenskliniek Stichting
2 months ago
New P2/3 trial
|
methylprednisolone acetate • methylprednisolone sodium succinate
2ms
IMHOA: The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis (clinicaltrials.gov)
P3, N=212, Recruiting, Sint Maartenskliniek
2 months ago
New P3 trial
|
methylprednisolone acetate • methylprednisolone sodium succinate
3ms
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression (clinicaltrials.gov)
P3, N=150, Recruiting, Hospital for Special Surgery, New York | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
3 months ago
Trial completion date • Trial primary completion date
|
methylprednisolone acetate
4ms
Conservative Treatment in Patients With Supraspinatus Tendon Injury. (clinicaltrials.gov)
P=N/A, N=40, Recruiting, Medical University of Lodz | Trial primary completion date: Jul 2025 --> May 2026
4 months ago
Trial primary completion date
|
methylprednisolone acetate
4ms
Hoffa's Fat Pad Impingement (HFPI) (clinicaltrials.gov)
P=N/A, N=62, Not yet recruiting, Boston Children's Hospital
4 months ago
New trial
|
methylprednisolone acetate • octreotide acetate
11ms
Comparison of the Efficacy of Two Different Suprascapular Nerve Block Techniques in Patients With Chronic Shoulder Pain (clinicaltrials.gov)
P=N/A, N=80, Completed, TC Erciyes University | Recruiting --> Completed
11 months ago
Trial completion
|
methylprednisolone acetate
11ms
Yale SEVEN: Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2 (clinicaltrials.gov)
P2, N=66, Recruiting, Yale University | Trial completion date: Mar 2026 --> Mar 2028 | Trial primary completion date: Mar 2025 --> Sep 2027
11 months ago
Trial completion date • Trial primary completion date
|
dexamethasone • methylprednisolone acetate
11ms
Yale SEVEN: Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study (clinicaltrials.gov)
P2, N=250, Recruiting, Yale University | Trial completion date: Mar 2026 --> Mar 2028 | Trial primary completion date: Mar 2025 --> Sep 2027
11 months ago
Trial completion date • Trial primary completion date
|
dexamethasone • methylprednisolone acetate
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.